Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,605-2,616 of 4,306
Drug study icon
CompletedNCT02079844

Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Denmark Hill
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Takeda
Condition
Schizophrenia
Device study icon
CompletedNCT03075202

Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 21 Years to 65 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00736710

rTMS Effects on Smoking Cessation and Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Device study icon
CompletedNCT01427088

rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Wanju
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceFrom 25 Years to 60 Years
Countries
South Korea
Sponsor
Jeonbuk Provincial Maeumsarang Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00968851

Safety and Cognitive Function Study of EVP-6124 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Russia, Serbia, ...
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Drug study icon
CompletedNCT00322023

Safety and Effectiveness of D-serine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
CompletedNCT00074477

Safety and Efficacy of an Anti-Psychotic in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01104766

Safety and Efficacy of Cariprazine in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Romania, Russia, ...
Sponsor
Forest Laboratories
Condition
Schizophrenia
Drug study icon
CompletedNCT01104779

Safety and Efficacy of Cariprazine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Costa Mesa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Colombia, India, ...
Sponsor
Forest Laboratories
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.